Poliovirus serological assay after the cVDPV1 outbreak in Papua New Guinea: a cross-sectional study from 2020 to 2021
Open Access
- 20 December 2023
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 44, 100986
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
- World Health Organization
This publication has 12 references indexed in Scilit:
- Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in VietnamJournal of the Pediatric Infectious Diseases Society, 2022
- A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in ChadJournal of the Pediatric Infectious Diseases Society, 2021
- Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in BeijingHuman Vaccines & Immunotherapeutics, 2020
- Strengthening routine immunization in Papua New Guinea: a cross-sectional provincial assessment of front-line servicesBMC Public Health, 2020
- Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response — Papua New Guinea, 2018MMWR. Morbidity and Mortality Weekly Report, 2019
- Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017Vaccine, 2018
- Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New GuineaPLOS ONE, 2017
- Standardized Methods for Detection of Poliovirus Antibodies2016
- Are hard-to-reach populations being reached with immunization services? Findings from the 2005 Papua New Guinea national immunization coverage surveyVaccine, 2010
- Papua New Guinea certified polio-free--complacency threatens dreams of eradication.2007